Kai Hu

Dr. Kai Hu

University of Massachusetts Medical School
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2017 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
AMAndrew J. Mitchell
Andrew J. Mitchell
NDNoah P. Dunham
Noah P. Dunham
RMRyan J. Martinie
Ryan J. Martinie
JBJonathan A. Bergman
Jonathan A. Bergman
CPChristopher J. Pollock
Christopher J. Pollock
ABAmie K. Boal
Amie K. Boal

6 February 2017 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
XZXufei Zhou
Xufei Zhou
XFXuezhu Feng
Xuezhu Feng
HMHui Mao
Hui Mao
MLMu Li
Mu Li
FXFei Xu
Fei Xu
SGShouhong Guang
Shouhong Guang

19 January 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MMMolly J. McBride
Molly J. McBride
SPSarah R. Pope
Sarah R. Pope
KHKai Hu
Kai Hu
COC. Denise Okafor
C. Denise Okafor
EBEmily P. Balskus
Emily P. Balskus
ABAmie K. Boal
Amie K. Boal
Significance: The enzyme SznF assembles the N -nitrosourea pharmacophore of the drug streptozotocin. Its N -oxygenase domain resembles heme-oxygenase (HO) and belongs to an emerging superfamily of HO-like diiron enzymes (HDOs) with unstable metallocofactors that have resisted structural characterization. Insight into cofactor dynamics from our prior investigation of SznF’s N -oxygenation reactions suggested an approach that has yielded a structure of a functionally assigned HDO with its diiron cofactor intact. Conformational changes accompanying cofactor (dis)assembly explain its instability, and the observation of an unanticipated glutamate ligand that is conserved in only a subset of HDO sequences provides a potential basis for top-level assignment of enzymatic function. Our results thus provide a roadmap for structural and functional characterization of novel HDOs.

17 September 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
EBElizabeth J. Blaesi
Elizabeth J. Blaesi
GPGavin M. Palowitch
Gavin M. Palowitch
KHKai Hu
Kai Hu
AKAmelia J. Kim
Amelia J. Kim
HRHannah R. Rose
Hannah R. Rose
ABAmie K. Boal
Amie K. Boal
All cells obtain 2′-deoxyribonucleotides for DNA synthesis through the activity of a ribonucleotide reductase (RNR). The class I RNRs found in humans and pathogenic bacteria differ in ( i ) use of Fe(II), Mn(II), or both for activation of the dinuclear-metallocofactor subunit, β; ( ii ) reaction of the reduced dimetal center with dioxygen or superoxide for this activation; ( iii ) requirement (or lack thereof) for a flavoprotein activase, NrdI, to provide the superoxide from O 2 ; and ( iv ) use of either a stable tyrosyl radical or a high-valent dimetal cluster to initiate each turnover by oxidizing a cysteine residue in the α subunit to a radical (Cys•). The use of manganese by bacterial class I, subclass b-d RNRs, which contrasts with the exclusive use of iron by the eukaryotic Ia enzymes, appears to be a countermeasure of certain pathogens against iron deprivation imposed by their hosts. Here, we report a metal-free type of class I RNR (subclass e) from two human pathogens. The Cys• in its α subunit is generated by a stable, tyrosine-derived dihydroxyphenylalanine radical (DOPA•) in β. The three-electron oxidation producing DOPA• occurs in Escherichia coli only if the β is coexpressed with the NrdI activase encoded adjacently in the pathogen genome. The independence of this new RNR from transition metals, or the requirement for a single metal ion only transiently for activation, may afford the pathogens an even more potent countermeasure against transition metal-directed innate immunity.

2 October 2020 in Genes
Verified
Journal Article
Open access
PDF file
RLRui Li
Rui Li
KHKai Hu
Kai Hu
HLHaibo Liu
Haibo Liu
MGMichael R. Green
Michael R. Green
LZLihua Zhu
Lihua Zhu
Over the past decade, a large amount of RNA sequencing (RNA-seq) data were deposited in public repositories, and more are being produced at an unprecedented rate. However, there are few open source tools with point-and-click interfaces that are versatile and offer streamlined comprehensive analysis of RNA-seq datasets. To maximize the capitalization of these vast public resources and facilitate the analysis of RNA-seq data by biologists, we developed a web application called OneStopRNAseq for the one-stop analysis of RNA-seq data. OneStopRNAseq has user-friendly interfaces and offers workflows for common types of RNA-seq data analyses, such as comprehensive data-quality control, differential analysis of gene expression, exon usage, alternative splicing, transposable element expression, allele-specific gene expression quantification, and gene set enrichment analysis. Users only need to select the desired analyses and genome build, and provide a Gene Expression Omnibus (GEO) accession number or Dropbox links to sequence files, alignment files, gene-expression-count tables, or rank files with the corresponding metadata. Our pipeline facilitates the comprehensive and efficient analysis of private and public RNA-seq data.

26 October 2015 in BMC Genomics
Verified
Journal Article
Open access
PDF file
YIYury V. Ivanov
Yury V. Ivanov
NSNikki Shariat
Nikki Shariat
KRKaren B. Register
Karen B. Register
BLBodo Linz
Bodo Linz
IRIsrael Rivera
Israel Rivera
ERIC HARVILLERIC HARVILL
ERIC HARVILL
Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated genes (cas) are widely distributed among bacteria. These systems provide adaptive immunity against mobile genetic elements specified by the spacer sequences stored within the CRISPR. The CRISPR-Cas system has been identified using Basic Local Alignment Search Tool (BLAST) against other sequenced and annotated genomes and confirmed via CRISPRfinder program. Using Polymerase Chain Reactions (PCR) and Sanger DNA sequencing, we discovered CRISPRs in additional bacterial isolates of the same species of Bordetella. Transcriptional activity and processing of the CRISPR have been assessed via RT-PCR. Here we describe a novel Type II-C CRISPR and its associated genes—cas1, cas2, and cas9—in several isolates of a newly discovered Bordetella species. The CRISPR-cas locus, which is absent in all other Bordetella species, has a significantly lower GC-content than the genome-wide average, suggesting acquisition of this locus via horizontal gene transfer from a currently unknown source. The CRISPR array is transcribed and processed into mature CRISPR RNAs (crRNA), some of which have homology to prophages found in closely related species B. hinzii. Expression of the CRISPR-Cas system and processing of crRNAs with perfect homology to prophages present in closely related species, but absent in that containing this CRISPR-Cas system, suggest it provides protection against phage predation. The 3,117-bp cas9 endonuclease gene from this novel CRISPR-Cas system is 990 bp smaller than that of Streptococcus pyogenes, the 4,017-bp allele currently used for genome editing, and which may make it a useful tool in various CRISPR-Cas technologies.